Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer

NCT00291707 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Cetuximab
DRUG: Pemetrexed
PROCEDURE: radiation therapy

Sponsor

University of Pittsburgh

Collaborators

[object Object]
[object Object]